Hims & Hers Health -12% after hours after FDA moves to restrict copycat weight loss drugs sold by pharma rivals

Source: [https://finance.yahoo.com/news/fda-restrict-glp-1-ingredients-220125448.html](https://finance.yahoo.com/news/fda-restrict-glp-1-ingredients-220125448.html)

>The U.S. Food and Drug ​Administration said on Friday ‌it plans to restrict GLP-1 ‌ingredients used in non-approved compounded drugs that companies such as Hims & Hers ⁠and other ‌compounding pharmacies have been marketing as alternatives ‍to authorized treatments, citing concerns over quality, safety and ​potential violations of federal ‌law.

>Shares of online telehealth company Hims and Hers Health fell nearly 10% in after-hours trade.

>The FDA ⁠said it is ​also taking ​steps to combat misleading direct-to-consumer advertising and marketing ‍following ⁠warning letters that were sent in the fall ⁠of 2025.

https://preview.redd.it/0k79gdx08yhg1.png?width=1582&format=png&auto=webp&s=670f6e760a9f10721cf8461336d1d93cf51bbfec